We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Monitoring Solution Enhances Safety of Cardiac Device Patients

By HospiMedica International staff writers
Posted on 10 Jun 2015
A new device keeps pacemaker and implantable cardioverter-defibrillator (ICD) wearers connected to their physician.

The CardioMessenger Smart provides fully automatic transmission of vital information from a patient’s cardiac implant to their physician over a GSM cellular network. More...
To use the device, the patient simply needs to connect it to a power source; it then automatically transmits the data to the BIOTRONIK Home Monitoring Service Center, using wireless, coded, telemetry. Consistent and reliable data transmission occurs both daily or when triggered by an event, and a call back message for patients enables physicians to get in contact with their patients whenever necessary.

BIOTRONIK Home Monitoring is intended to replace device interrogation during in-office follow-up visits, and to provide early detection of arrhythmias. It is available in over 55 countries, optimizing patient management around the world. Features offered include intelligent early detection, customizable fully programmable alerts with options to specify alert thresholds and ranges, and call-back alerts to notify the patient to contact the clinic. BIOTRONIK Home Monitoring and the CardioMessenger Smart are products of BIOTRONIK (Berlin, Germany).

“Recent years have seen a shift towards early detection and prevention. By helping healthcare providers better manage their patients, Home Monitoring improves the efficacy and safety of cardiac rhythm therapy,” said Wolf Ruhnke, vice president of BIOTRONIK. “Patient-centric advanced technologies like Home Monitoring allow implant patients to go about their lives with the peace of mind that comes from knowing they are taken care of, anywhere, anytime.”

“Home Monitoring alerts me to relevant changes in patient or device status, ensuring that I always see the right patient at the right time,” said Volker Leonhardt, MD, director of telemedicine at Herzschrittmacher-Zentrum (HIZ; Berlin, Germany; www.stimulation.de). “I can keep track of each patient without subjecting him to needlessly intrusive in-person follow-ups and react quickly when necessary. This has clear clinical advantages for the patient, especially for heart failure patients.”

Related Links:

BIOTRONIK
Herzschrittmacher-Zentrum



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.